CHH-380

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCHH-380
Drug Alias NameSDZ CHH 380Chimeric anti-CD7 antibodyCHH-380
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionT-cell antigen CD7 inhibitorsImmunosuppressants
TargetsT-cell antigen CD7
Therapy Area/IndicationsRejection of organ transplantationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCelltechNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelltechNovartis Pharma Ag +[3] 
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A